Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medimass was a medical technology company focused on the development of the iKnife, an intelligent surgical tool that utilizes mass spectrometry for real-time tissue analysis. The company's proprietary Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology analyzes the smoke plume generated during electrosurgery to provide surgeons with immediate diagnostic information. This allows for the precise differentiation between cancerous and healthy tissue during operative procedures, potentially improving surgical outcomes and reducing the need for follow-up surgeries. Founded in Budapest, Hungary, Medimass was acquired by Waters Corporation in 2014 to expand their clinical and diagnostic mass spectrometry capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medimass Research Development.